Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Dissemination Events - Priority Announcement: Cancer Research

University of Toronto

$7,500.00

Symposium "Epigenetics of Cancer and Stem Cells"

EF 2011-12

Résumé
The "Epigenetics of cancer and stem cells" symposium will be held in Toronto, Canada on February 27-28, 2012. This symposium will be the fifth in a series of meetings organized by the Structural Genomics Consortium (SGC) discussing the relevance of epigenetics to specific diseases and health areas. The expected number of participants is 300 scientists, a majority of whom will be Canadian. With 15 invited speakers, from various research backgrounds, the symposium is expected to have a large impact on sharing the advances and latest technologies relevant to developing novel therapeutics for cancer and epigenetics. Epigenetics is a new field that studies how the packaging of our genetic material (DNA) is involved in normal health and disease. The field is advancing at an exponential rate as more epigenetic mechanisms are uncovered in biological processes including cancer, stem cell biology, inflammation and mental illness. There is great optimism that many new therapeutic strategies will emerge from epigenetics research, especially being able to tailor therapeutic approaches on a personal basis (personalized medicine). This Symposium will be a forum for exchange of information and new research results among basic and clinical scientists to enhance our understanding of the role of epigenetics in cancer, stem cell biology and personalized treatments. Participants will come from Canadian and international academic groups, and the pharmaceutical industry. The Symposium also aims to make the Canadian and International epigenetics community aware of recent work in the development of open-access chemical probes and antibodies thereby fostering wider collaboration and dissemination of new technologies and reagents. Additionally, through the SGC's contacts, the Symposium will encourage participation and interaction of the Canadian research community with pharmaceutical scientists in epigenetics drug discovery in order to maximize knowledge translation.
Programme
Dissemination Events - Priority Announcement: Cancer Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
245941
Name
Arrowsmith Cheryl H
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Dissemination Events Grants
Projecttitle
Symposium "Epigenetics of Cancer and Stem Cells"
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Toronto
Cihramount2
$7,500
Cihrequipment2
$0
Programname2
Dissemination Events - Priority Announcement: Cancer Research
Keyworddelim
Antibodies; Cancer; Cancer Stem Cells; Chemical Probes; Drug Discovery; Epigenetics; Histone Modifications; Personalized Medicine; Stem Cells
Abstract
The "Epigenetics of cancer and stem cells" symposium will be held in Toronto, Canada on February 27-28, 2012. This symposium will be the fifth in a series of meetings organized by the Structural Genomics Consortium (SGC) discussing the relevance of epigenetics to specific diseases and health areas. The expected number of participants is 300 scientists, a majority of whom will be Canadian. With 15 invited speakers, from various research backgrounds, the symposium is expected to have a large impact on sharing the advances and latest technologies relevant to developing novel therapeutics for cancer and epigenetics. Epigenetics is a new field that studies how the packaging of our genetic material (DNA) is involved in normal health and disease. The field is advancing at an exponential rate as more epigenetic mechanisms are uncovered in biological processes including cancer, stem cell biology, inflammation and mental illness. There is great optimism that many new therapeutic strategies will emerge from epigenetics research, especially being able to tailor therapeutic approaches on a personal basis (personalized medicine). This Symposium will be a forum for exchange of information and new research results among basic and clinical scientists to enhance our understanding of the role of epigenetics in cancer, stem cell biology and personalized treatments. Participants will come from Canadian and international academic groups, and the pharmaceutical industry. The Symposium also aims to make the Canadian and International epigenetics community aware of recent work in the development of open-access chemical probes and antibodies thereby fostering wider collaboration and dissemination of new technologies and reagents. Additionally, through the SGC's contacts, the Symposium will encourage participation and interaction of the Canadian research community with pharmaceutical scientists in epigenetics drug discovery in order to maximize knowledge translation.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Arrowsmith, Cheryl H
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $7,500~ $0~